|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 2059246 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07826167.4 |
| Date of filing the European patent application | 2007-08-28 | |
| (97) | Date of publication of the European application | 2009-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-16 |
| (46) | Date of publication of the claims translation | 2014-01-27 |
| (86) | Number | PCT/IB2007/053448 |
| Date | 2007-08-28 |
| (87) | Number | WO 2008/026156 |
| Date | 2008-03-06 |
| (30) | Number | Date | Country code |
| PCT/IB2006/0529 | 2006-08-29 | WO | |
| PCT/IB2006/0538 | 2006-10-19 | WO |
| (72) |
CLOZEL, Martine, CH
|
| (73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapinės kompozicijos, apimančios specifinį endotelino receptoriaus antagonistą ir PDE5 inhibitorių |
| Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 19 | 347.00 EUR |
| 2026-08-28 |